Bayro I.M.

Bayro I.M. may be available in the countries listed below.

Ingredient matches for Bayro I.M.

Etofenamate

Etofenamate is reported as an ingredient of Bayro I.M. in the following countries:

• Ecuador

International Drug Name Search

Torasemida Tarbis

Torasemida Tarbis may be available in the countries listed below.

Ingredient matches for Torasemida Tarbis

Torasemide

Torasemide is reported as an ingredient of Torasemida Tarbis in the following countries:

• Spain

International Drug Name Search

Metformine Pfizer

Metformine Pfizer may be available in the countries listed below.

Ingredient matches for Metformine Pfizer

Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformine Pfizer in the following countries:

• France

International Drug Name Search

Depakote

See also: Generic Depakote ER

Depakote is a brand name of divalproex sodium, approved by the FDA in the following formulation(s):

DEPAKOTE (divalproex sodium - capsule, delayed rel pellets; oral)

• 
  Manufacturer: ABBOTT
  
  Approval date: September 12, 1989
  
  Strength(s): EQ 125MG VALPROIC ACID ^[RLD][AB]

DEPAKOTE (divalproex sodium - tablet, delayed release; oral)

• 
  Manufacturer: ABBOTT
  
  Approval date: March 10, 1983
  
  Strength(s): EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[RLD][AB]


• 
  Manufacturer: ABBOTT
  
  Approval date: October 26, 1984
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB]

Has a generic version of Depakote been approved?

A generic version of Depakote has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Depakote and have been approved by the FDA:

divalproex sodium capsule, delayed rel pellets; oral

• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: January 23, 2009
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: March 28, 2011
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: January 27, 2009
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB]

divalproex sodium tablet, delayed release; oral

• 
  Manufacturer: ANCHEN PHARMS
  
  Approval date: November 3, 2008
  
  Strength(s): EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA LTD
  
  Approval date: April 21, 2011
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: DR REDDYS LABS LTD
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: LUPIN
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: March 17, 2009
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: NU PHARM
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: ORCHID HLTHCARE
  
  Approval date: November 25, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: SUN PHARM INDS
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: TEVA
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: UNICHEM LABS LTD
  
  Approval date: April 5, 2011
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: UPSHER SMITH
  
  Approval date: July 29, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: VINTAGE
  
  Approval date: November 30, 2009
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: WATSON LABS FLORIDA
  
  Approval date: February 25, 2011
  
  Strength(s): EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: WOCKHARDT
  
  Approval date: July 31, 2008
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]


• 
  Manufacturer: ZYDUS PHARMS USA INC
  
  Approval date: March 5, 2009
  
  Strength(s): EQ 125MG VALPROIC ACID ^[AB], EQ 250MG VALPROIC ACID ^[AB], EQ 500MG VALPROIC ACID ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Depakote. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Depakote.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • March 24, 2011 - EXPANDED INFORMATION TO PEDIATRIC USE SUBSECTION OF LABELING IN RESPONSE TO PEDIATRIC WRITTEN REQUEST
  
  
  • September 24, 2011 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Depakote Consumer Information (Drugs.com)
• Depakote Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Depakote Sprinkle Capsules Consumer Information (Wolters Kluwer)
• Depakote Consumer Information (Cerner Multum)
• Depakote Advanced Consumer Information (Micromedex)
• Divalproex Delayed-Release Tablets Consumer Information (Wolters Kluwer)
• Divalproex Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Divalproex Sprinkle Capsules Consumer Information (Wolters Kluwer)
• Divalproex sodium Consumer Information (Cerner Multum)
• Alti-Valproic Advanced Consumer Information (Micromedex)
• Depakote DR Advanced Consumer Information (Micromedex)
• Divalproex sodium Advanced Consumer Information (Micromedex)

Amlodipina

Amlodipina may be available in the countries listed below.

Ingredient matches for Amlodipina

Amlodipine

Amlodipina (DCIT) is known as Amlodipine in the US.

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Econor

Econor may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Econor

Valnemulin

Valnemulin hydrochloride (a derivative of Valnemulin) is reported as an ingredient of Econor in the following countries:

• Austria


• Belgium


• Finland


• Germany


• Italy


• Sweden


• Switzerland


• United Kingdom

International Drug Name Search

Napro

Napro may be available in the countries listed below.

Ingredient matches for Napro

Naproxen

Naproxen is reported as an ingredient of Napro in the following countries:

• Bangladesh

International Drug Name Search